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Elucidation of complex phenotypes for mechanistic
insights presents a significant challenge in systems
biology. We report a strategy to automatically infer
mechanistic models of cell fate differentiation based
on live-imaging data. We use cell lineage tracing and
combinations of tissue-specific marker expression
to assay progenitor cell fate and detect fate changes
upon genetic perturbation. Based on the cellular
phenotypes, we further construct a model for how
fate differentiation progresses in progenitor cells
and predict cell-specific gene modules and cell-to-
cell signaling events that regulate the series of fate
choices. We validate our approach in C. elegans
embryogenesis by perturbing 20 genes in over 300
embryos. The result not only recapitulates current
knowledge but also provides insights into gene func-
tion and regulated fate choice, including an unex-
pected self-renewal. Our study provides a powerful
approach for automated and quantitative interpreta-
tion of complex in vivo information.
INTRODUCTION
A desired framework for systematic understanding of biological
processes would include regulatory networks from molecules to
cellular behavior and then from cellular behavior to organismal
function. Recent progress in 3D time-lapse imaging has pro-
vided an unprecedented opportunity to dissect complex in vivo
phenotypes and achieve systems-level understanding of devel-
opment (Megason and Fraser, 2007). In particular, development
of diverse organisms can be imaged with single-cell resolution
over an extended period of time (Busch et al., 2012; Keller,
2013). However, the biological complexity of development com-
bined with the sheer amount of data from live imaging presents a
significant challenge on how to extract useful phenotypic infor-
mation and how to translate the information into mechanistic
understanding.
C. elegans has proven to be an effective model for systems
biology, especially for inferring gene networks based on in vivo
phenotypes (Green et al., 2011; Gunsalus et al., 2005; Lehneret al., 2006; Liu et al., 2009; Murray et al., 2012). In particular,
developmental phenotypes during C. elegans embryogenesis
can be systematically dissected on a cell-by-cell basis.
C. elegans embryogenesis follows an invariant cell lineage to
generate 558 differentiated cells (Sulston et al., 1983). The ste-
reotypical cellular behaviors in proliferation, differentiation, and
morphogenesis further simplify systematic single-cell phenotype
analysis (Bao et al., 2008; Giurumescu et al., 2012; Hench et al.,
2009; Moore et al., 2013; Schnabel et al., 1997; So¨nnichsen
et al., 2005). Highly automated cell lineage tracing has been
developed based on 3D time-lapse imaging using fluorescently
labeled histones to track cells (Bao et al., 2006; Mace et al.,
2013). This automation opened a door to process developmental
information from large image data sets.
In this study, we present an approach to infer systems-level
mechanistic models of development de novo from live-imaging
data based on automated phenotype analysis. Our study is
focused on the regulation of cell fate differentiation. The fate of
a progenitor cell is manifested as the distinct set of specialized
cell types that it gives rise to. Following this concept, our
approach uses cell lineage tracing and combinations of cell-
type-specific marker expression to assay progenitor cell fate. It
then uses automated reasoning to detect fate changes in individ-
ual progenitor cells upon genetic perturbation. In particular, it
identifies homeotic transformations and infers the primary site
of the fate phenotype. Based on the cellular phenotypes, it
further constructs a directed graph as a model for how fate
differentiation progresses in progenitor cells and predicts gene
modules and cell-to-cell signaling events that regulate the series
of fate choices. The automated reasoning and interpretation of
phenotypes are based on general logic without prior knowledge
of gene function or the expectation of specific phenotypes.
We validated our approach in C. elegans embryogenesis by
perturbing 20 widely conserved regulatory genes. We assayed
cell fate differentiation in over 300 embryos in strains expressing
reporter transgenes for five tissue types. Our analysis success-
fully recovered the known phenotypes and functions of the
20 genes. The systems-level model essentially recapitulates
the current understanding of differentiation in the early embryo.
More importantly, the analysis identified 14 new phenotypes
caused by inactivation of seven of the genes and six new types
of homeotic transformations that reveal previously unknown
binary fate choices in development. We further validated one
of the insights, namely the turnover of a lineage specifier as aCell 156, 359–372, January 16, 2014 ª2014 Elsevier Inc. 359
Figure 1. Strategy Overview
(A) Development was recorded by 3D time-lapse imaging. Differentiation was
digitized by cell lineage tracing and determining single-cell expression status
of tissue markers. See also Movie S1.
(B) Fate of progenitor cells (numbered circles) was defined retrospectively by
assaying the combinatorial expression pattern (CEP) of tissue markers in
resulting terminal cells.
(C) Systematic comparison of CEPs between progenitor cells in wild-type and
perturbed embryos detects fate changes. Homeotic transformations (red
arrow) were identified.
(D) Detected fate changes were used to infer a systems-level mechanistic
model of how gene modules and cell-to-cell signaling events regulate fate
choices as differentiation progresses.
360 Cell 156, 359–372, January 16, 2014 ª2014 Elsevier Inc.binary switch between self-renewal and differentiation. These
results demonstrate a powerful approach to analyze complex
in vivo phenotypes using imaging to achieve a systems-level
mechanistic understanding of development.
RESULTS
Design of Strategy
Our approach to infer mechanistic models of cell fate differenti-
ation involves multiple layers of information processing. We first
review the overall strategy of our approach here and then further
describe the major components in the subsequent sections.
As illustrated in Figure 1, our approach consists of four major
components:
Imaging and Digitization of Differentiation
We performed 3D time-lapse imaging of development and digi-
tized the information on differentiation by systematic cell lineage
tracing and tissue marker expression profiling at a single-cell
resolution (Figure 1A).
Definition of Progenitor Cell Fate
We used a retrospective approach to define the fate of individual
progenitor cells based on expression pattern of multiple tissue
markers in terminal cells they give rise to (Figure 1B). The combi-
natorial expression pattern (CEP) can be thought of as a unique
barcode to define the progenitor cell fate. To do so, we devel-
oped computational methods to synthesize CEPs from multiple
markers, measure the similarity between CEPs, and classify
the CEPs that capture the different progenitor cell fates in the
wild-type.
Detection of Fate Changes
Upon genetic perturbations, we detected progenitor cell fate
changes by comparing the CEPs of the progenitor cells
between wild-type and perturbed embryos (Figure 1C). From
the changes, we identified homeotic fate transformations where
the fate of one progenitor cell is transformed to that of another.
Our computational method incorporates automated reasoning
to handle incomplete penetrance and pleiotropy and to infer
the primary fate change.
Inference of Systems-Level Mechanistic Model of
Differentiation
We combined cell lineage and fate assessment to infer how dif-
ferentiation progresses in progenitor cells and used the detected
fate transformations to infer regulated binary fate choices during
the process (Figure 1D). In order to predict the genemodules and
cell-cell signaling events that regulate the cascade of binary
fate choices, we constructed gene-gene and cell-cell networks
based on phenotypic similarities. Finally, all results were inte-
grated into a mechanistic model revealing a molecular and
cellular regulatory network controlling cell fate differentiation
in vivo.
We validated our strategy in C. elegans embryogenesis by
inferring the systems-level mechanistic model underlying the
specification of 13 early progenitor cells that have been classi-
cally defined as founder cells. Each of these founder cells
exhibits a distinct fate and gives rise to a distinct set of differen-
tiated cell types (Sulston et al., 1983).
When developing the algorithms, we followed the general logic
used in developmental genetics rather than C. elegans-specific
Figure 2. Experimental Definition of Progenitor Cell Fates
(A) Digitization of differentiation. Left: markers for the five major tissues.
Middle: a ubiquitously expressed histone marker (red) was used for de novo
construction of cell lineage. Right: expression level of tissue marker (green)
was measured at every time point and averaged over a cell’s lifetimerules. In the following sections, we describe the specific design
of each component as well as the key technical and biological
considerations. Due to space limitations, more detailed informa-
tion is provided in Extended Experimental Procedures. When
appropriate, we describe the performance and validation of
our methods.
Imaging and Digitization of Differentiation
To profile the differentiation of embryonic cells, we performed 3D
time-lapse imaging to record embryogenesis and used auto-
mated image analysis to track cells and assay tissue marker
expression (Bao et al., 2006; Murray et al., 2008, 2012; Santella
et al., 2010). Specifically, we used a ubiquitously expressed his-
tone-fluorescent protein fusion to label all cells, which allowed us
to track every cell and reconstruct the cell lineage. An additional
fluorescent protein fused to a tissue-specific gene allowed us to
determine the cell type (Figure 2A). Overall, we used five strains,
each carrying a ubiquitous marker and a tissue-specific marker,
to systematically profile the differentiation of the major tissue
types of C. elegans (Figure 2A; Table S1 available online).
We imaged embryogenesis at a fine temporal resolution (75 s)
for the first 7 hr of development (Movie S1). We digitized the pro-
cess by tracing the entire cell lineage and measuring marker
expression through the first nine out of a total of ten rounds of
cell division. By this stage, the embryo contains about 350 cells
and has completed gastrulation and major tissue/organ
patterning, providing sufficient information about differentiation
(Sulston et al., 1983). Each digitized embryo contains quantita-
tive data on the position and marker expression level of every
cell at every time point. For this study, we further processed
the information to a binary call on whether a cell expresses a
tissue marker or not (Figures 2A, S1A and S1B).to determine the tissue type of individual terminal cells. See also Figures S1A
and S1B.
(B) A consensus cell lineage and marker expression patterns. The 13 founder
cells of interest are indicated using colored circles and cell names. Colors in
lineage tree indicate expressing cells for each marker. Black branches
represent nonexpressing cells. See also Figure S1C.
(C) Quantitative description of expression patterns via clonal expression
analysis. For a given marker within the sublineage of a given founder cell (X),
maximal clones with uniform expression and significant size (horizontal
arrows) were identified. The lineal ID of the progenitor of each expressing and
nonexpressing clones (red and white dots) and the frequency of expressing
cells within each clone were used to describe the expression pattern of the
marker. See also Figures S1D–S1F.
(D) CEP of five markers captures fate of a corresponding progenitor cell.
Figure shows the CEP for the MS cell. Note that the yellow branches (stars)
show consistent expression of the CND-1 marker, but no expressing clones
were defined (CND-1 in bottom), because of the nonsignificant clone size.
(E) Free combination of single-marker expression patterns to synthesize
CEPs. Each barcode represents a single-marker expression pattern for a cell
of interest. CEP was synthesized using a free-combination strategy and for
each CEP one expression pattern per marker was used.
(F) Classification of CEPs. 3D scatter plot shows the distribution of wild-type
CEPs in an abstract space. The three axes are the first three principal
components, which are abstract orthogonal dimensions suggested by a
principal-component analysis (PCA) that show the highest variance among the
samples (CEPs). CEPs belonging to different founder cells are in different
color as in (B). Arrow indicates CEPs of ABplp and ABprp. See also Figures
S1G and S1H.
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CEP-Based Assessment of Progenitor Cell Fate
A progenitor cell generates a specific set of cell types. For a
given progenitor cell, we assayed its fate retrospectively using
the CEP of tissue-specific markers in its sublineage (Figure 2B).
We describe below three key aspects for using CEPs to system-
atically and objectively detect progenitor fates: (1) the set of
tissue markers used, (2) the computational approach to define
CEPs, and (3) methods to compare and classify the CEPs of
different progenitor cell fates.
Selection of Markers
We used five well-characterized tissue-specific genes to
generate the CEPs used to distinguish progenitor fates. These
genes encodemaster transcription factors that drive the differen-
tiation of the major tissue/cell types ofC. elegans, namely nhr-25
(skin), cnd-1 (a subset of neurons), pha-4 (pharynx and gut), elt-2
(gut), and hnd-1 (body wall muscle). We used available protein
fusion fluorescent reporters for these genes,which are integrated
into the genome. The expression pattern of thesemarkers agrees
well with the known function and endogenous expression of
these genes in the literature. Details on these markers, including
gene function, expression patterns, transgenic methods, and
supporting literature, are provided in Table S1.
The major consideration in selecting a marker was its ability to
distinguish the different founder cell lineages. An ideal marker
would generate unique and easily distinguishable lineage pat-
terns of expression for different progenitor cells, and a given
set of markers should generate unique combinations of lineage
patterns for each of the progenitor cells of interest (Figure 2B).
Furthermore, the expression pattern should be reproducible
so that the pattern can be reliably compared between embryos.
The five markers used all showed high reproducibility (r > 0.9,
n = 10 for each marker; Figure S1C). They were also sufficient
to generate distinguishable combinatorial patterns as readouts
of early progenitor cell fates (see below). In short, for a useful
marker, the uniqueness and reproducibility of lineage expres-
sion pattern are more important than the precise tissue details
of its expression pattern. Our use of five markers was a prac-
tical decision to balance workload and the risk of erroneous
fate calls. Additional discussions regarding marker choice are
provided in the Extended Experimental Procedures (General
Considerations).
Computational Approach to Define CEPs
Our computational definition of CEPs included two steps: (1)
define the expression pattern of a single marker in a sublineage
and (2) combine the patterns of multiple markers into a CEP.
To define the expression pattern of a single marker in a given
sublineage, we described the pattern as a set of clonal expres-
sion sites (Figure 2C). A clonal expression site is a maximal clone
(horizontal arrows in Figure 2C) with uniform expression (fraction
of expressing cells within the clone > 0.85) and significant size
(binomial test, p < 0.01; Extended Experimental Procedures).
The expression pattern was then described as a list of the ex-
pressing and the complementary nonexpressing clones. Each
clone was described by two factors: the lineal identity of the
founder cell of the clone (red and white dots and cell names in
Figure 2C) and the fraction of expressing cells within the clone
(numbers 1.00 and 0.00 in Figure 2C). Biologically, the clonal
sites reflect the underlying differentiation program within a given362 Cell 156, 359–372, January 16, 2014 ª2014 Elsevier Inc.sublineage. In particular, the lineal identity of the clonal sites
reflects the invariable developmental programs in the lineage.
Technically, the use of clonal sites provides robustness to the
subsequent computational analyses in terms of variations of
marker expression and lineaging errors (see Extended Experi-
mental Procedures, General Considerations).
To combine the expression pattern of multiple markers into a
CEP, we simply used a list of each marker’s pattern (Figure 2D).
The number of markers that can be assayed in a single specimen
through live imaging is limited due to technical considerations.
Therefore, we developed computational methods to combine
the expression of different markers from multiple embryos. A
key step in doing so was to identify the equivalent cells across
embryos. The general approach requires anatomy-based align-
ment between specimens (e.g., corresponding tissue layers after
spatial alignment). However, because of the invariant cell lineage
in C. elegans and the stereotypical orientation of each mitosis
(Sulston et al., 1983), the lineal name of a cell provides the equiv-
alent information to its anatomical position. Therefore, in our
approach, cells with the same lineal name in different embryos
were taken as equivalent cells.
We imaged multiple embryos for each tissue-specific marker.
To synthesize the CEP for a given cell, we exhausted all combi-
nations of the defined single-marker expression patterns for that
cell, with each combination containing one defined pattern per
marker (Figure 2E). For example, if two embryos were imaged
for each of the five markers, this would yield 25 = 32 instances
of CEP for a given cell. With a naive approach to enumerate all
combinations, the computational loadwill increase exponentially
with the number of markers used. To reduce the computational
task, we developed an algorithm where the amount of computa-
tion increases linearly with the number of markers (see Extended
Experimental Procedures). Implications of this free-combination
approach are addressed below in ‘‘Detection of Fate Changes.’’
Methods to Compare and Classify CEPs
In order to use CEPs to assay progenitor cell fate, we first devel-
oped methods to quantify pairwise similarity between CEPs. We
then defined the distinct classes of CEPs among the 13 founder
cells in the wild-type embryos. Combining these two pieces
allowed us to assay the fate of a progenitor cell by comparing
its CEP to the wild-type CEP classes.
To determine how similar two CEPs are, we calculated an ab-
stract distance between the two. Specifically, we enumerated
each clonal expression site of eachmarker, calculated the differ-
ence in the fraction of expressing cells at each site, and summed
the differences to compute the distance (Figure S1E; Extended
Experimental Procedures). Using this quantitative measure of
similarity, we examined the CEPs of the 13 founder cells based
on the five markers in 50 wild-type embryos (ten embryos for
each marker). We found that the CEPs fell in 12 distinct classes.
The intraclass distances were significantly less than the inter-
class distances (Figures 2F and S1H; t test, two tailed, p <
0.001). The fates of the ABplp and ABprp cells were indistin-
guishable (arrow in Figure 2F). The differences between the
two are known to be subtle, which involve a handful of terminal
cells at sub-tissue-type level (Sulston et al., 1983). Hence, with
the five markers, our CEP-based approach can distinguish 12
unique progenitor cell fates.
The above analysis also allowed us to define the consensus
and variance for each of the 12 classes of wild-type CEPs (Fig-
ure S1I), which were in turn used as references to classify the
CEPs observed in progenitor cells in mutants/RNAi. An observed
CEP is considered a match for one of the 12 classes if the dis-
tance to the reference is statistically indistinguishable from the
corresponding intraclass distance (t test, p > 0.05).
The above clonal-site-based description of expression pattern
maximizes the use of information provided by an invariant line-
age. To consider the more general cases where the sublineage
of a founder cell could be variable, we also developed an alter-
native definition that describes the pattern as the fraction of
terminal cells expressing a marker within the entire founder cell
lineage (Figure S1D). This approach forgoes the lineage structure
and the biological assumption of fate commitment in intermedi-
ate cells, making it broadly applicable to different developmental
scenarios. CEPs defined by this alternative approach were suffi-
cient to distinguish the 12 major progenitor cell fates (Figures
S1G and S1H), demonstrating that the general strategy of
CEP-based automated assessment of cell fate is not restricted
to invariant cell lineages. As expected, this fraction-based
approach was less robust in distinguishing CEPs with fine differ-
ences in marker expression patterns (circles in Figure S1G; see
also Figures S1E and S1F for comparison). We therefore used
the clonal-site-based definition in subsequent analyses.
Detection of Fate Changes
We used the 12 defined wild-type CEP classes to detect progen-
itor cell fate changes in perturbedembryos. In particular,we iden-
tified homeotic transformations among the detected changes.
We developed computational methods for automated reasoning
based on general logic of developmental genetics. These
methods were designed to detect fate changes in the face of
complication from incomplete penetrance and pleiotropy and
to infer the primary fate changes from secondary phenotypes.
General Strategy
The 12 classes of wild-type CEPs were used as a reference to
detect the occurrence of the 12 fates in the progenitor cells of
perturbed embryos (Figure 3A). In addition to examining the 13
founder cells, we also examined their ancestor and daughter
cells to assess potential premature and delayed differentiation
phenotypes. Thus, we examined 51 progenitor cells in total (Fig-
ure S2A). Logical rules to reconcile the results when fate changes
are detected in both a cell and itsmother are defined in Extended
Experimental Procedures.
Three outcomes of CEP detection are expected (Figure 3B): (1)
the CEP of a progenitor matches its wild-type counterpart, sug-
gesting no fate change; (2) the CEP of a progenitor matches a
CEP that is normally associatedwithanother progenitor, suggest-
ing a homeotic transformation; and (3) the CEP of a progenitor
matches none of the defined wild-type classes, suggesting that
the progenitor cell adopts an undefined/uninterpretable fate. A
typical example of (3) is global dysregulation of gene expression.
Incomplete Penetrance
When a phenotype is not fully penetrant, the same cell may
exhibit different fates in different embryos (wild-type fate in
some embryos and perturbed fate in others). As described
above, we synthesized CEPs from multiple embryos by freelycombining across all embryos and markers. This free-combina-
tion approach has a distinct advantage in handling incomplete
penetrance: the different fates are included in the set of synthe-
sized CEPs as distinct CEPs instead of being averaged into a
meaningless pattern. However, the free combination will also
lead to artifactual CEPswhere expression patterns from different
fates are mixed (Figure 3C).
We used two strategies to address these artifacts. First, we
examined if a mixture of two wild-type classes of CEPs would
generate an artifactual CEP that matches a third fate following
free combination. We simulated all pairwise mixtures (12 3 11/
2 = 66 pairs) and detected only one type of artifactual match un-
der our similarity measure and cutoffs, namely the CEP of ABala.
This is because none of the fivemarkers used is expressed in the
ABala lineage and an all-blank CEP is expected to arise as an
artifact given the restricted expression of the tissue-specific
markers. In order to address this limitation, we developed
methods to process the artifactual ABala fate when it occurred
(Extended Experimental Procedures). Second, we allowed mul-
tiple classes of CEPs to be detected for a given cell but only
accepted undefined CEPs (undefined/uninterpretable fates)
when no homeotic transformations were detected (Figure 3D).
This rule allowed the detection of bona fide uninterpretable fates
while avoiding the artifactual combinations.
Pleiotropy
When a gene functions in many cells, the pleiotropic phenotype
is naturally elucidated by our cell-by-cell analysis. When a gene
has multiple functions in a cell, its disruption may produce
different fate outcome in the cell across embryos in combination
with incomplete penetrance. Needless to say, the methods
above also apply here. It is worth noting that the methods above
accept multiple distinct homeotic transformations for a cell,
which cope with multiple gene functions (Figure 3D).
Primary Sites of Homeotic Transformation
Some of the homeotic transformations detected are expected
to be secondary phenotypes derived from earlier changes in their
ancestor cells. We developed methods to infer primary pheno-
types from the detected changes so that the results would be
more indicative of the regulatory mechanisms. We followed the
parsimony principle to infer the primary site of transformation:
when transformations were detected in both sister cells, we
assumed that a transformation occurred in the mother cell, and
we did so iteratively to find the earliest one (Figure 3E). Additional
rules to infer primary sites and the new fate of a primary site are
detailed in Extended Experimental Procedures and Figures S2B
and S2C. It is worth noting that these inferred sites are primary
site of homeotic transformation, but they could still be secondary
phenotypes in terms of gene function.
In summary, our CEP-based phenotype analysis systemati-
cally detects and processes fate changes in individual progenitor
cells during development. It reports primary sites of fate changes
and classifies changes as homeotic transformations or fate
dysregulation (Figure S2A).
Validation of Methods: De Novo Phenotype Analysis of
Master Developmental Regulators
Weapplied theaboveapproach to20genes thatarewell knownas
key regulators in diverse biological processes (Figure 4A). All 20Cell 156, 359–372, January 16, 2014 ª2014 Elsevier Inc. 363
Figure 3. Detection of Cell Fate Changes
(A) Detection of fate changes by CEPmatch. Wild-type CEPs (top) were used to systematically detect the occurrence of the 12 founder fates in progenitor cells of
perturbed embryos (bottom) based on quantitative comparison (arrows). MOM-2 is the C. elegans homolog of Wnt. Red arrows indicate detected homeotic
transformations. See also Figure S2A.
(B) Three outcomes of CEP detection and their interpretations.
(C) Complications caused by incomplete penetrance. Free combination generates artifactual CEPs in the presence of incomplete penetrance. Figure shows an
example where a cell exhibits thewild-type fate and the corresponding single-marker expression patterns (left column) in some embryos and the transformed fate
and expression patterns in others (right column). Each box represents a single-marker expression pattern and color represents type of marker. The artifactual
CEP would not match any defined wild-type CEP classes. It is rejected if another CEP is interpreted as a homeotic transformation (see B and D).
(D) Rules to process phenotype outcomes under incomplete penetrance. + and  indicate presence and absence, respectively. See the Extended Experimental
Procedures for details.
(E) Parsimony to infer primary fate change. When transformations (red) are detected in both sister cells, we assume a change in the mother cell and do so
iteratively to find the primary change. See also Figures S2B and S2C.genes have been characterized to some extent in C. elegans,
providing a solid and extensive benchmark to test our approach.
We used RNAi to knock down each gene and analyzed two to
six embryos for each of the five markers, totaling 260 embryos
(Figures 4B–4D). Together with 50 wild-type embryos, our data
set contains 310 embryos (Tables S2 and S3). Using the above
methods,wedetected 95 fate changes, including 23deduced pri-
marysites.Of these,55aredetectedashomeotic transformations,
involving 17 pairs of progenitor cell fates (Figure 4E; Table S4).
We benchmarked the accuracy of these results in the following
two ways. First, we examined the classification of the observed364 Cell 156, 359–372, January 16, 2014 ª2014 Elsevier Inc.CEPs. The new CEPs after the presumed homeotic transforma-
tions clustered tightly with the corresponding class in the wild-
type (Figure 4F), suggesting that the detected transformations
under our similarity measurements and cutoff are clean and
valid. More specifically, our experimental data included single-
maker expression patterns in 3,380 (13 3 260) founder cell
sublineages (Figure 4G). Of these, 3,006 or 89% matched a
wild-type counterpart. The remaining cases fell in three cate-
gories based on human evaluation. A total of 5.4%were deemed
slight variations of the wild-type counterpart, which were
rejected by our stringent cutoff. A total of 2.1% were deemed
partial transformations. The last category (3.5%) involved two
situations: dysregulation of differentiation (such as in hda-1/
HDAC) or complex functions in the sublineage that affect the
expression pattern (such as pop-1/TCF). Second, we compared
the 55 detected homeotic transformations to the literature. We
correctly captured 22 out of 25 known phenotypes (Figure 4H;
Table S4). The discrepancy came from three categories. The first
was the absence of phenotypes, presumably due to the low
penetrance of phenotypes in our RNAi treatments (e.g., pal-1/
Caudal and src-1/FYN). The second was due to complex func-
tion of a gene in the sublineage that affects the tissue marker
expression pattern (e.g., pop-1/TCF), so that the result could
not be matched to the expected CEPs. The third was insufficient
merging of secondary sites into the known primary site of fate
change. This affected only one situation in our data, namely,
the transformation of ABp to its sister ABa upon the loss of first
Notch induction (Schnabel and Priess, 1997). The complication
arises because the progeny of the transformed ABp receive
ectopic fate inductions subsequently, so that the tissue marker
expression pattern does not perfectly match the ABa progeny
pattern. For clarity, we manually corrected the case in the third
category in Figure 4E. Both the second and third categories
reflect our choice to match cell fate with caution and stringent
cutoffs. Furthermore, of the 33 phenotypes that have not been
reported before, 19 can be deduced from the literature (Fig-
ure 4H; Table S4), further validating the accuracy of our results.
Importantly, our results revealed 14 new phenotypes for 7 of
the 20 genes (Table S4), including 6 new types of homeotic trans-
formations. It is worth noting that many of these new phenotypes
were detected based on the inactivation of highly pleiotropic
genes, such as gsk-3/gsk3b and skr-1/2/Skp1. These results
demonstrate that our methods are particularly powerful in eluci-
dating pleiotropic effects that are composed of many specific
phenotypes while refraining from overinterpreting global dysre-
gulation. Furthermore, our methods also successfully handled
the complex situation of a gene with nested multiple functions
in a lineage, such as in the cases of glp-1/Notch in the ABp
lineage or skr-1/2/Skp1 in the C cell (Figure 4E). This is due
to the incomplete penetrance of earlier functions in our RNAi
treatments that allows the phenotypes of a later function to be
observed and to the ability of our methods to synthesize CEPs
from alternative phenotypes while rejecting artifactual combina-
tions of expression patterns.
In summary, our approach successfully recapitulates known
gene functions in embryogenesis while also identifying new
gene functions and types of homeotic transformations.
Validation of a New Phenotype: Protein Degradation
Drives Transition of Cell Fate
A particularly interesting type of homeotic transformation
occurred when a daughter cell adopts the fate normally associ-
ated with its mother cell, that is, self-renewal. RNAi depletion
of skr-1/2/skp1, a component of the SCF E3 ubiquitin ligase
component, caused such phenotypes in several blastomeres,
including EMS, C, and P3 (Figure 4E). These results raised the
possibility that protein degradation controls the choice between
self-renewal and differentiation and drives timely progression
of cell fate.To examine this possibility, we investigated the function of
skr-1/2 in one of the cases, namely, the endomesoderm differ-
entiation in the EMS lineage. The endomesoderm is derived
from a single blastomere at the four-cell stage named EMS. A
sharp transition of fate occurs upon EMS division. The anterior
daughter, named MS, differentiates into future mesoderm,
whereas the posterior daughter, E, differentiates into the future
endoderm (Figure 5A).
We first verified that in skr-1/2(RNAi) the anterior daughter,
MS, reiterated the EMS fate. In addition to the general tissue
fate patterning that led to the automated prediction (Figure 5B),
we found extensive evidence that MS generated the precise
EMS lineage, including using additional transgenic reporters
(Table S5), single-cell behaviors (programmed cell death, spindle
orientation, gastrulation), cell proliferation, and overall tissue
morphogenesis (Figures S3A–S3D). Second, we found in skr-1/
2(RNAi) the EMS blastomere behaved as in the wild-type: it
showed molecular and cellular behaviors that are specific to
the wild-type EMS blastomere (Figures 5C and 5D). Collectively,
these results suggest a reiteration instead of delayed specifica-
tion of EMS fate or a dramatic fate change of early blastomeres.
Similarly, we found that loss of function of another component of
SCF (the Cullin protein CUL-1/CUL1, n = 9) and a subunit of the
26S proteasome complex (RPN-8/PSMD7, n = 2), phenocopied
skr1/2(RNAi) (Figures S3E and S3F). These results suggest that
skr-1/2 functions through the SCF E3 ligase complex-mediated
protein degradation to promote the transition of cell fate from
EMS to its anterior daughter.
We found that skr-1/2 promoted EMS fate transition by re-
stricting the temporal expression of SKN-1/Nrf1/2, a conserved
bZip transcription factor that specifies the EMS fate (Bowerman
et al., 1992). During normal development, SKN-1 shows tran-
sient expression in the EMS blastomere but rapidly diminishes
upon EMS division so that no SKN-1 is detectable in later-stage
EMS daughter cells (Bowerman et al., 1993; Page et al., 2007).
We found that skr-1/2 was required for timely degradation of
SKN-1 during EMS-to-MS transition. We used a SKN-1::GFP
reporter to monitor SKN-1 expression (Page et al., 2007). In
skr-1/2(RNAi), the initial level in the EMS blastomere was com-
parable to the wild-type. However, the reduction of protein level
over time was significantly dampened and SKN-1 persisted for
an additional cell cycle (Figure 5E). Importantly, we found that
delayed degradation of SKN-1 caused EMS self-renewal. We
overexpressed SKN-1::GFP under a heat-shock promoter. After
heat shock, a high level of SKN-1::GFP was induced and sus-
tained for approximately one additional cell cycle in the EMS
lineage (Figure 5F). Concomitantly, we detected reiteration of
the EMS fate (n = 15). Quantitative analysis of cell fate showed
that as in skr-1/2(RNAi), in SKN-1 overexpression the CEPs of
the MS cell was indistinguishable from that of wild-type EMS
fate (Figure 5G; CEP distance = 0.05 and = 0.03, p = 0.6 and
0.8, respectively) but was significantly different from that of
wild-type MS fate (CEP distance = 1.49 and 1.48, p = 0 for
both cases). More significantly, two rounds of EMS reiteration
were induced when SKN-1::GFP was sustained for two addi-
tional cell cycles (Figure S3G; n = 7). Taken together, our results
suggest that SCF controls self-renewal by promoting the turn-
over of SKN-1.Cell 156, 359–372, January 16, 2014 ª2014 Elsevier Inc. 365
Figure 4. De Novo Phenotype Analysis of Master Developmental Regulators
(A) List of the 20 genes examined.
(B) Representative micrographs (3D projections) showing the terminal phenotypes of RNAi. Top row shows the wild-type.
(C) Heatmap display of expression patterns. Marker expression in terminal cells (cyan box in left) was used as a summary heatmap for display. Cells are ordered
based on the lineage, with founder cell names listed on top. Different tissue markers are in different colors as in Figure 2A.
(legend continued on next page)
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In all, the above results validated the automatically detected
skr-1/2(RNAi) phenotype as a fate reiteration/self-renewal of
EMS and further dissected the underlying mechanism where
protein degradation of amaster transcription factor controls pro-
gression of differentiation (Figure 5H). The analysis of cell fate at
single-cell resolution pinpoints the phenotype to a failure of fate
transition between a mother cell and its daughters, ruling out
alternative explanations that gross terminal phenotype assays
could not eliminate, such as impaired execution of downstream
differentiation or mitotic exit. These results show that turnover of
a lineage specifier functions as a binary switch between self-
renewal and differentiation.
Systems-Level Model of Differentiation
Finally, we analyzed the detected cell fate phenotypes to infer a
systems-level mechanistic model of differentiation. The model
consists of three components: (1) a directed graph representing
how fate differentiation progresses over development along with
the fate choices during the process, (2) cell-specific gene mod-
ules, and (3) cell-cell signaling events that regulate fate choices.
Fate Progression and Fate Choices
Weused a directed graph to represent the progression of cell fate
(Figures 6A and6B). In such a graph, nodes represent the progen-
itor cell fates, arrows represent the trajectoriesof fateprogression,
and bifurcations represent fate choices. Differentiation during
normal development can be inferred from the wild-type cell line-
age, which yields trajectories of fate progression bifurcating
from themother to twodaughter-cell fates (Figure 6A, top). Home-
otic transformations reveal additional binary fate choices. Each
transformation between non-sister-cell fates reveals such a fate
choice that is not evident from normal development. In these
cases, we added a new arrow bifurcating from the mother to
two fates (Figure 6A, bottom). For transformations between sis-
ter-cell fates, the binary fate choice is already captured by the
bifurcations constructed from the wild-type (Figure 6A, middle).
By integrating all detected homeotic transformations, the
resulting graph provides a model of fate progression during
development (Figure 6B). Themodel includes 24 progenitor fates
observed in the wild-type (12 founder cell fates and 12 ancestor
cell fates) and three non-wild-type ancestor fates (see Extended
Experimental Procedures for definition and Figure S2C). It also
represents 26 binary fate choices (points in Figure 6B). Six of
these are new fate choices revealed by this study (red stars in
Figure 6B). Fate choices between nonsister fates reflect nonde-
terministic differentiation in C. elegans (Schnabel and Priess,
1997) as well as multipotent and reprogrammable fates in the
early blastomeres.
Gene Modules and Cell-Cell Signaling
Fate changes implicate the perturbed genes as regulators of dif-
ferentiation. In total, we identified 55 homeotic transformations(D) Heatmap display of the five markers in the 260 RNAi-treated embryos in this
shows the wild-type expression pattern. See also Table S3.
(E) Detected primary sites of homeotic transformations. Affected cells are in red
(F) 3D scatterplot shows the distribution of CEPs that are classified as homeotic tr
The wild-type classes are organized as in Figure 2F. Two classes with the highe
(G) Classification of founder cell CEPs in all RNAi-treated embryos.
(H) Summary of literature comparison. See also Table S4.caused by loss of the 20 genes (Figure 6C). The cellular resolu-
tion of phenotypes allowed us to further analyze the regulatory
mechanisms in terms of gene modules and cell-to-cell signaling
events that regulate fate choices. We did so by constructing
gene-gene and cell-cell networks.
We first constructed a gene network by measuring phenotypic
similarity between genes. We measured phenotypic similarity by
calculating the pointwisemutual information between genes (see
Extended Experimental Procedures for details). Because of the
directionality of homeotic transformations (Figure 6D), our anal-
ysis was able to link not only genes with the same regulatory
function but also those with opposite functions (red and blue
edges in Figure 6E, respectively). Of the reported edges in the
network (Figure 6E), those with two or more shared phenotypes
are highlighted with thick lines. The predicted gene network
successfully captures the three known molecular modules
contained in the 20 genes, namely, the Notch pathway, the
Wnt pathway, and the PAR polarity pathway (dashed circles).
All other thick edges are also consistent with the literature (Table
S4), except those between gld-2 and the Wnt pathway, which
have not been reported before. GLD-2 is an RNA-binding protein
in the germline and the Wnt pathway components functioning
in the early embryo are provided maternally. Therefore, we
consider these thick edges a prediction that gld-2 regulates
the Wnt pathway, which remains to be tested experimentally.
Furthermore, the cellular-resolution phenotypes allowed us to
construct a cell-cell network. The cell-cell network links cells that
show correlated fate changes across perturbations (Figure 6F).
We quantified the degree of correlation by calculating the
pointwise mutual information between cells. We used this cell-
cell network to predict cell-to-cell signaling events. This was
based on the argument that if the fate of a signaling cell is
perturbed, then the fate of the receiving cell should show corre-
lated changes. An alternative reason for apparently correlated
changes between cells is that the perturbed gene functions inde-
pendently in the two cells. To minimize the inclusion of this alter-
native scenario, the cell-cell network was filtered by additional
information such as cell position (i.e., potential cell contact)
and independence of phenotypes in two cells within each indi-
vidual embryo (Extended Experimental Procedures). The result-
ing network includes 12 cell pairs. These results capture all six
known signaling events in the studied time window, namely,
the four Notch signaling events (Schnabel and Priess, 1997)
and two Wnt signaling events (Eisenmann, 2005). The predicted
Notch and Wnt signaling events are confirmed by the pheno-
types in the presumptive receiving cells caused by the genes
in these pathways (green boxes in Figure 6F). Only three of the
12 pairs are potentially false-positive predictions where corre-
lated fate changes reflect independent functions of genes in
two cells. This cell-cell network analysis enriches for cell-to-cellstudy. Each row is an embryo as in (C) with the same color scheme. Top row
and the arrows represent the type and direction of transformation.
ansformation (open circles) and the corresponding wild-type references (dots).
st variability (associated with the MS and C fates) are shown in insets.
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Figure 5. Protein Degradation Drives Transition of Cell Fate
(A) Transition of cell fate in the wild-type endomesodermal lineage. Colored tree shows expression of pharynx, muscle, and gut markers in EMS lineage. In
addition to cell lineage and fate patterning, characteristic single-cell behaviors including cell death (X) and left-right cell division (L/R) are also shown. See also
Figures S3A–S3D.
(B) MS acquires EMS fate in skr-1/2(RNAi). See also Figures S3A–S3F.
(C and D) Fate of the EMS blastomere is specified correctly. (C) The ability of EMS to receive and respond to signals from the neighboring P2 cell to rotate its
spindle from an initial left-right alignment to anterior-posterior (Eisenmann, 2005). (D) The ability of EMS to signal to P2 to orient PAR-2 polarity (Arata et al., 2010).
Spindle (arrowheads) rotation in the EMS cell and PAR-2 polarity in P2 (arrows) are indistinguishable between the wild-type and skr-1/2(RNAi). Scale bar, 10 mm.
(E) skr-1/2(RNAi) causes delayed degradation of SKN-1. Left: micrographs of embryos with SKN-1::GFP expression (green). Arrowheads highlight EMS, MS
and two MS daughter cells. SKN-1::GFP signal in other blastomeres at four-cell stage is due to the maternal load (Page et al., 2007). Right: quantification of
SKN-1::GFP levels (mean ± SD.; p value was estimated by two-tailed t test)
(F) Left: heat-shock-induced overexpression leads to sustained SKN-1::GFP in MS, E, and their daughter cells. Scale bar, 10 mm. Right: reiteration of EMS fate in
MS under heat-shock-induced overexpression of SKN-1::GFP. See also Figure S3G.
(G) Quantitative analysis of cell fate. Scatterplot shows the distribution of CEPs of the MS cell in skr-1/2(RNAi) and SKN-1 overexpression relative to the normal
MS and EMS fates in an abstract space.
(H) Summary of results.signaling events for over 30-fold. It is worth noting that, as in
any computational analyses, the predictions need further exper-
imental validation, but the results suggest that our cell-cell
network analysis provides a powerful approach to identify poten-
tial signaling events from complex phenotype data.368 Cell 156, 359–372, January 16, 2014 ª2014 Elsevier Inc.Integrated Model
We integrated the directed graph of fate progression, gene reg-
ulators, and cell-to-cell signaling into a mechanistic model of dif-
ferentiation at a systems level (Figure 7). In the model, cell fates,
trajectories of fate differentiation, and binary fate choices are
Figure 6. Systems-Level Analysis of Differentiation
(A) Rules to construct a directed graph of fate progression and fate choices. Top: wild-type cell lineage was used to construct a directed graph of fate (numbered
nodes) progression (arrows) and binary fate choices (dots) during normal development. Middle and bottom: homeotic transformations (red arrows) were used to
infer additional binary fate choices and trajectories of fate progression. See main text for details.
(legend continued on next page)
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drawn as in Figure 6B. Genes are associated with the individual
fate choices they regulate (Figure 7A, left). We defined the direc-
tionality of gene function arbitrarily. For homeotic transformation
between sister fates, we drew the corresponding gene as a
positive regulator of the fate it promotes. For transformations
between nonsister fates, we drew the gene as a repressor of
the alternative fate. If multiple genes regulate the same fate
choice/bifurcation, the network topology is inherited from Fig-
ure 6E (Figure 7A, middle). This should not be confused with
genetic epistasis among these genes, because our single-gene
perturbations do not provide the required information to estab-
lish genetic epistasis. The exceptions are the Notch and Wnt
pathway components, which are ordered based on their molec-
ular identities.
The cell-cell network further reduces redundancy of informa-
tion in the phenotype data set. When a gene affects two cells
that are linked by a signaling event, we mapped the gene only
to the signaling cell under the assumption that the gene functions
indirectly in the receiving cell. Genes that affected only the
receiving cell are considered components or modulators of the
underlying signaling pathway (Figure 7A, right). Signaling events
are drawn as thin yellow arrows originating from the predicted
signaling cell and pointing to the presumed pathway compo-
nents of the receiving cell.
Together, this molecular and cellular regulatory network sum-
marizes how gene modules and signaling events regulate the
progression of cell fate differentiation (Figure 7B). The informa-
tion was extracted from 3D time-lapse images of development
through a series of computational analyses (Figure 7C) and
provides a systems-level view of the complex development
processes of an early metazoan embryo with predicted in vivo
regulatory mechanisms.
DISCUSSION
In summary, our study establishes an approach to automatically
infer systems-level mechanistic models of development from
live-imaging data. The CEP analysis and automated reasoning
convert the large number of secondary phenotypes, namely
the expression of tissue-specific markers in terminal cells,
into the primary fate changes in the progenitor cells, which
allows the additional inference of developmental mechanisms.
Importantly, the cellular-resolution phenotype data enabled us
to design novel systems biology analyses with rich biological(B) The graph integrating all results from the wild-type and the detected homeo
trajectories of fate progression (black: trajectories inferred from normal develop
revealed in this study). Points highlight binary fate choices (open: choice between
green: choice between sister fates that were perturbed; red: choice between n
bifurcation points. When a fate can be transformed to more than one other fate
Additional genetic experiments would be needed to order them. See also Figure
(C) Matrix summarizing all detected homeotic transformations. Fates of progenit
(D) Genes inducing identical transformations (e.g., 5/4) are considered as having
13 versus 13/12) are considered as having opposite function.
(E) Gene network. Edges with two or more shared phenotypes are shown in thic
(F) Cell-cell network. Known events of Wnt and Notch signaling are highlighted b
signaling pathways that affect the receiving cell are labeled on the receiving cell
(blue). Cyan arrow represents an ectopic third Notch signal from ABar daughter (
that are inevitable in network inference.
370 Cell 156, 359–372, January 16, 2014 ª2014 Elsevier Inc.insights. The analyses allowed us to construct an explicit model
of how cell fate differentiation progresses and to predict the
gene-gene and cell-cell signaling networks during development.
Additional discussion regarding the experimental design (choice
of markers and alternative approaches of genetic perturbation)
and computational design (robustness to experimental varia-
tions) is provided in the Extended Experimental Procedures
(General Considerations) and Figure S4.
The automated reasoning and interpretation of phenotypes are
based on general logic of developmental genetics without prior
knowledge of gene function or the expectation of specific pheno-
types. While the invariant cell lineage of C. elegans plays an
important role in our study at the technical level, the logic used
behind the automated reasoning as well as the approaches to
implement the logic aredesigned tocomplywith regulativedevel-
opment and variable cell lineage. As shown in this study, the CEP
analysis does not require an invariant cell lineage (Figures S1D–
S1H) or an assumption of one cell per fate. However, it would
require anatomy-based spatial registration of specimens so
that equivalent cells can be identified and compared between
samples. Automated spatial registration has been shown to be
practical in complex organisms, especially with the aid of addi-
tional molecular markers (Fowlkes et al., 2008). Live imaging pro-
vides accessibility to many developmental processes in vivo in
organisms with regulative development (Busch et al., 2012; Kel-
ler, 2013). Our study suggests that with continued cell-tracking
improvements (Keller et al., 2010; Santella et al., 2010), auto-
mated approaches can also be successful in processing and
interpreting the large amount of complex information in images
to arrive at mechanistic insights in more complex organisms.
We envision that automated phenotype analyses like ours will
greatly accelerate the study of development, where hundreds
of mutants can be routinely analyzed with single-cell resolution
to produce systems-level mechanistic models. Many animal
groups exhibit invariable development as C. elegans but are
understudied in terms of the genetic regulatory networks. Our
approach allows de novo construction of mechanistic models
of development without extensive prior knowledge. Hence,
with genome sequencing, RNAi, and emerging tools for targeted
genome engineering, as well as imaging-based cell lineage anal-
ysis, especially by differential interference contrast microscopy
(Schnabel et al., 1997), the strategy described here can be
applied to such organisms to rapidly broaden our understanding
of the development of multicellular organisms.tic transformations. Nodes represent progenitor cell fates. Arrows represent
ment; blue: trajectories inferred from RNAi phenotypes; star: new trajectories
sister fates inferred from normal development and not perturbed in our data set;
onsister fates). The regulators are placed near the corresponding perturbed
, the corresponding trajectories and bifurcation points are ordered arbitrarily.
S2C.
or cells are indicated by numbers.
same regulatory function and genes inducing opposite transformations (12/
k lines. Dashed circles highlight the three known genetic modules.
y red arrows, from signaling cell to receiving cells. Genes in the corresponding
(green boxes). Genes that perturb both cells are labeled on the signaling cell
ABara) to ABpra that occurs when ABar/ABal. Stars indicate redundant links
Figure 7. Inferred Mechanistic Model of Development
(A) Rules to integrate results. Left: a homeotic transformation phenotype is interpreted as a regulated binary fate choice, with the perturbed gene as the regulator
at the corresponding bifurcation. Middle: genes with identical phenotype are organized based on topology of gene network (direct links) in Figure 6E to regulate
fate choices. Right: cell-cell signaling is used to reduce redundant information of gene function. See main text for details.
(B) Integrated model based on this study. Fate progression and binary choices are represented as in Figure 6. Predicted Wnt and Notch signaling events are
shown as yellow arrows from the signaling cell to the receiving cell. Genes in these pathways are colored as green (Wnt) and dark red (Notch) and ordered based
on molecular identity.
(C) Flow of information.
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EXPERIMENTAL PROCEDURES
All experimental procedures, including experimental and computational
methods, are detailed in the Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four
figures, five tables, and one movie and can be found with this article online
at http://dx.doi.org/10.1016/j.cell.2013.11.046.
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